Anne P. O’Dea

1.8k citations
26 papers · 1.0k · 2 hit papers · h-index 14

Impact in

    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics
  • Oncology top 10%
    • HER2/EGFR in Cancer Research
    • Cancer Immunotherapy and Biomarkers
    • Cancer Cells and Metastasis

Papers in

    • Breast Cancer Treatment Studies 6
    • Cancer Genomics and Diagnostics 4
    • Cancer Cells and Metastasis 3
    • HER2/EGFR in Cancer Research 3
    • Cancer Treatment and Pharmacology 2

Anne P. O’Dea

25 papers receiving 1.0k citations

Anne P. O’Dea's Hit Papers

Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer 2023 · 125 citations
1250+1+2Years since publication4080120

Peers

Anne P. O’Dea
Comparison fields: 5 of 81
  • Cancer Research 326
  • Oncology 434
  • Pulmonary and Respiratory Medicine 257
  • Pathology and Forensic Medicine 121
  • Genetics 39
Replace Sanyuan Sun with:
Sanyuan Sun China
Parvin F. Peddi United States
Theresa W. McHugh United Kingdom
Keren B. Sturtz United States
Penny J. Powers United States
Joan Barbara Heijns Netherlands
Lola Anagnostaki Sweden
Mona El-Hashimy United States
Hongyu Zhang China
Po‐Han Lin Taiwan
Anne P. O’Dea relative to Sanyuan Sun China Sanyuan Sun's profile →
Citations per field
00.5×1.6×
Sanyuan Sun · 1×
Citations per year

Countries citing papers authored by Anne P. O’Dea

Since Specialization
Citations

This map shows the geographic impact of Anne P. O’Dea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne P. O’Dea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne P. O’Dea more than expected).

Fields of papers citing papers by Anne P. O’Dea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne P. O’Dea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne P. O’Dea. The network helps show where Anne P. O’Dea may publish in the future.

Co-authors

The 25 scholars most cited alongside Anne P. O’Dea, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anne P. O’Dea Line = papers co-authored together Anne P. O’Dea links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2009155
2
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: MAINTAIN Trial
Hit paper breakdown →
2023137
3
Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer
Hit paper breakdown →
2023125
4 201898
5 202076
6 201068
7 201865
8 202256
9 202155
10 202153
11 200737
12 202335
13 200519
14
Clinicopathological characteristics of triple-negative invasive mammary carcinomas in African-American versus Caucasian women.
201016
15 202414
16 202411
17 20187
18 20254
19 20234
20 20174

About Anne P. O’Dea

Anne P. O’Dea is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Genetics and Pathology and Forensic Medicine, having authored 26 papers that have together received 1.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (6 papers), Advanced Breast Cancer Therapies (5 papers), Cancer Genomics and Diagnostics (4 papers), Cancer Cells and Metastasis (3 papers), HER2/EGFR in Cancer Research (3 papers), Estrogen and related hormone effects (2 papers), BRCA gene mutations in cancer (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Cancer Research (326 citations), Oncology (434 citations), Pulmonary and Respiratory Medicine (257 citations), Pathology and Forensic Medicine (121 citations) and Genetics (39 citations). Anne P. O’Dea has collaborated with scholars based in United States, Australia and Spain. Frequent co-authors include Qamar J. Khan, Priyanka Sharma, Carol J. Fabian, Bruce F. Kimler, Jennifer R. Klemp, Pavan S. Reddy, Lauren Elizabeth Nye, Jamie Lynn Wagner, Christa Balanoff and Kelsey E. Larson. Their work appears in journals such as Clinical Cancer Research, Journal of Clinical Oncology, npj Breast Cancer, Clinical Breast Cancer and Nature Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact